Loading...

A145 “REAL WORLD” SAFETY AND EFFECTIVENESS OF VEDOLIZUMAB FOR ULCERATIVE COLITIS: RETROSPECTIVE STUDY FROM A TERTIARY CARE CANADIAN CENTRE

BACKGROUND: Vedolizumab (VDZ), a humanized monoclonal antibody which targets the α4β7 integrin and prevents homing of lymphocytes to the gut, was approved by Health Canada in 2015 for treatment of moderate to severe ulcerative colitis (UC). Its gut selective mode of action offers potential for a low...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Can Assoc Gastroenterol
Main Authors: Kwapisz, L, Jairath, V, Karthik, V, Beaton, M D, Gregor, J C, Khanna, R, Ponich, T, Sey, M, Yan, B, Chande, N
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2018
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6507784/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy008.146
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!